Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | RDY | SUPN | ||
| Company | Cymabay Therapeutics | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 32.49 | 14.34 | 51.65 | ||
| High | 32.50 | 14.48 | 51.65 | ||
| Low | 32.48 | 14.27 | 50.03 | ||
| Latest | 32.48 | 14.42 | 50.20 | ||
| Change | +0.01 | +0.02 | -1.42 | ||
| % Change | +0.03% | +0.14% | -2.75% | ||
| Volume | 8,356,200 | 2,457,826 | 494,613 | ||
| 20-Day Average Volume | 3,390,805 | 2,126,071 | 701,811 | ||
| Previous Close | 32.47 | 14.40 | 51.62 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 13.87 | 49.76 | ||
| 20-Day Raw Stochastic | 94.12% | 96.51% | 61.91% | ||
| 20-Day Relative Strength | 78.00 | 60.29 | 51.62 | ||
| Weighted Alpha | +247.60 | +7.49 | +51.70 | ||
| Today's Opinion | 100% Buy | 8% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | +2.71% since 02/10/26 | -1.91% since 02/10/26 | ||
| Low | 32.44 on 03/15/24 | 14.05 on 02/11/26 | 49.46 on 02/13/26 | ||
| High | 32.50 on 03/21/24 | 14.48 on 02/18/26 | 51.97 on 02/17/26 | ||
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | +11.61% since 01/16/26 | +0.40% since 01/16/26 | ||
| Low | 32.15 on 02/22/24 | 12.81 on 01/20/26 | 47.29 on 02/03/26 | ||
| High | 32.50 on 03/21/24 | 14.48 on 02/18/26 | 51.99 on 02/06/26 | ||
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | +2.85% since 11/18/25 | +11.80% since 11/18/25 | ||
| Low | 22.11 on 01/26/24 | 12.81 on 01/20/26 | 44.09 on 12/02/25 | ||
| High | 32.50 on 03/21/24 | 14.48 on 02/18/26 | 52.50 on 01/12/26 | ||
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | +1.34% since 08/18/25 | +16.77% since 08/18/25 | ||
| Low | 12.32 on 10/13/23 | 12.81 on 01/20/26 | 41.78 on 08/20/25 | ||
| High | 32.50 on 03/21/24 | 15.06 on 09/17/25 | 57.65 on 10/30/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 12,023,106 | 2,959,839 | ||
| Shares Outstanding, K | 114,724 | 834,938 | 57,339 | ||
| Annual Sales | 31,070,000 | 3,811,000,000 | 661,820,000 | ||
| Annual Net Income | -105,370,000 | 663,000,000 | 73,870,000 | ||
| Last Quarter Sales | 60,000 | 977,400,000 | 192,100,000 | ||
| Last Quarter Net Income | -41,900,000 | 135,500,000 | -45,120,000 | ||
| 60-Month Beta | 0.32 | 0.35 | 0.71 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.19 on 10/24/25 | 1.01 on 11/04/25 | ||
| Latest Earnings Date | 05/20/24 | 05/08/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | 0.071 on 07/25/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/25/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.36 | 23.87 | ||